Hikma Injectables USA Inc recalls ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc
Recalled January 8, 2025 · FDA recall D-0173-2025 · Hikma Injectables USA
Hazard
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment. · FDA Class II
Units
1,800 syringes
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Product
ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25
Manufacturer(s)
Hikma Injectables USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →